The longevity industry is projected to reach a £20 trillion valuation by 2030, yet emerging research suggests effective interventions may be far simpler and less costly than the luxury treatments dominating headlines.
Data Bridge market research estimates the global longevity sector will hit £20 trillion ($25.3 trillion) within six years, driven by high-end offerings like Clinique La Prairie’s £30,000 ($38,000) “Revitalisation” retreats and £5,800 ($7,300) therapeutic plasma exchanges favored by celebrities and affluent wellness seekers.
However, Dr. Josh Berkowitz of IVBOOST UK argues that meaningful longevity gains stem from accessible, everyday habits rather than expensive interventions, emphasizing sleep quality and vitamin D supplementation as foundational, low-cost strategies.
Meanwhile, clinical evidence supports specific supplements for measurable biological impacts: a trial of nearly 800 adults over 70 found daily omega-3 supplementation correlated with a biological age reduction of approximately three months after three years, as measured by DNA methylation clocks.
Creatine, widely studied for athletic performance, also shows promise for longevity through its role in ATP regeneration, cognitive function, and neuroprotection, with researchers noting its benefits extend beyond muscle mass to cellular energy metabolism and brain health.
Omega-3 fatty acids, particularly EPA and DHA, help regulate inflammation rather than eliminate it, supporting recovery, joint integrity, cardiovascular function, and long-term disease risk by guiding the body back toward equilibrium after physical stress.
In a separate six-month study, adults aged 40 and older taking NOVOS Core demonstrated a 2.9% improvement in flow-mediated dilation — a measure of endothelial function — sustained over time, alongside a 6.1 mmHg reduction in systolic blood pressure, even among those with normal baseline readings.
The arterial flexibility improvements from NOVOS Core matched or exceeded those seen in studies of sustained high-intensity interval training and Mediterranean diet interventions, suggesting the supplement may deliver cardiovascular benefits comparable to established lifestyle interventions.
These findings highlight a growing divergence in the longevity market: while luxury wellness experiences attract media attention and high spending, scientific evidence increasingly points to affordable, evidence-based nutrients and habits as drivers of meaningful biological aging modulation.
The supplement industry’s tendency to promote novel compounds often obscures the consistent data behind established nutrients, leading experts to advocate for simplicity and reproducibility over marketing-driven trends.
Researchers stress that the real value of supplements like creatine, omega-3s, and formulations such as NOVOS Core emerges not from isolated use but from consistent, long-term integration into daily routines.
For individuals seeking longevity benefits, the convergence of evidence supports prioritizing sleep hygiene, vitamin D repletion, and evidence-based supplements over costly, unproven modalities — a shift that could democratize access to science-backed aging interventions.
What is the most evidence-backed supplement for slowing biological aging?
Based on current clinical trials, daily omega-3 supplementation shows the strongest direct evidence for slowing biological aging, with a study of nearly 800 adults over 70 linking it to a three-month reduction in biological age after three years.
Can supplements like NOVOS Core replace exercise or diet for heart health?
No; while NOVOS Core demonstrated improvements in arterial function and blood pressure comparable to those from high-intensity interval training and Mediterranean diets, researchers position it as a complement to, not a replacement for, proven lifestyle interventions.
